Trends in Iowa Wildlife Populations and Harvest 2011, October 2012

A report by the Iowa Department of Natural Resources on the trends of Iowa wildlife populations and harvest.

Trends in Iowa Wildlife Populations and Harvest 2012, October 2013

A report by the Iowa Department of Natural Resources on the trends of Iowa wildlife populations and harvest.

Trends in Iowa Wildlife Populations and Harvest 2013, December 2014

A report by the Iowa Department of Natural Resources on the trends of Iowa wildlife populations and harvest.

Trends in Iowa Wildlife Populations and Harvest 2001, October 2002

A report by the Iowa Department of Natural Resources on the trends of Iowa wildlife populations and harvest.

Trends in Iowa Wildlife Populations and Harvest 2002, September 2003

A report by the Iowa Department of Natural Resources on the trends of Iowa wildlife populations and harvest.

Trends in Iowa Wildlife Populations and Harvest 2003, December 2004

A report by the Iowa Department of Natural Resources on the trends of Iowa wildlife populations and harvest.

Trends in Iowa Wildlife Populations and Harvest 2004, October 2005

A report by the Iowa Department of Natural Resources on the trends of Iowa wildlife populations and harvest.

Trends in Iowa Wildlife Populations and Harvest 2005, December 2006

A report by the Iowa Department of Natural Resources on the trends of Iowa wildlife populations and harvest.

Trends in Iowa Wildlife Populations and Harvest 2006, December 2007

A report by the Iowa Department of Natural Resources on the trends of Iowa wildlife populations and harvest.

Trends in Iowa Wildlife Populations and Harvest 2007, September 2008

A report by the Iowa Department of Natural Resources on the trends of Iowa wildlife populations and harvest.

Trends in Iowa Wildlife Populations and Harvest 2008, September 2009

A report by the Iowa Department of Natural Resources on the trends of Iowa wildlife populations and harvest.

Rural Expressway Intersection Synthesis of Practice and Crash Analysis, 2004

This report presents a national synthesis of rural expressway, two-way stop -controlled (TWSC) intersection safety strategies and intersection designs and an analysis of Iowa expressway TWSC intersection crash characteristics. A rural expressway is a multi-lane highway with a divided median and with mostly at -grade intersections, although some intersections may be grade separated. The synthesis of intersection strategies is conducted in two parts. The first is a literature review and the second part is a national survey of strategies currently being applied by state transportation agencies. The characterization of crash patterns at TWSC expressway intersections is examined through the analysis of 5 years of crash data at 644 intersections.

Journalistic practice in risk and crisis situations: Significant examples from Spain

In a democratic society, the media are central to the communication of risks and uncertainties to the public. This article presents 10 proposals for improving media coverage in social risk situations. The article focuses on the production logic of the media and its consequences for society. The proposals and the conclusions of this research are supported by an analysis of three Spanish cases: the risk implied by the Tarragona chemical complex (one of the biggest in Europe); the terrorist attacks on 11 March 2004 in Madrid; and the Carmel tunnel disaster in Barcelona on January 2005. The authors are participating in a research project on public perception of risk funded by the Spanish Education Ministry on public perception of risk (2004–2007 and 2007–2010).

Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

OBJECTIVE: To determine whether differences in short-term virologic failure among commonly used antiretroviral therapy (ART) regimens translate to differences in clinical events in antiretroviral-naïve patients initiating ART. DESIGN: Observational cohort study of patients initiating ART between January 2000 and December 2005. SETTING: The Antiretroviral Therapy Cohort Collaboration (ART-CC) is a collaboration of 15 HIV cohort studies from Canada, Europe, and the United States. STUDY PARTICIPANTS: A total of 13 546 antiretroviral-naïve HIV-positive patients initiating ART with efavirenz, nevirapine, lopinavir/ritonavir, nelfinavir, or abacavir as third drugs in combination with a zidovudine and lamivudine nucleoside reverse transcriptase inhibitor backbone. MAIN OUTCOME MEASURES: Short-term (24-week) virologic failure (>500 copies/ml) and clinical events within 2 years of ART initiation (incident AIDS-defining event, death, and a composite measure of these two outcomes). RESULTS: Compared with efavirenz as initial third drug, short-term virologic failure was more common with all other third drugs evaluated; nevirapine (adjusted odds ratio = 1.87, 95% confidence interval (CI) = 1.58-2.22), lopinavir/ritonavir (1.32, 95% CI = 1.12-1.57), nelfinavir (3.20, 95% CI = 2.74-3.74), and abacavir (2.13, 95% CI = 1.82-2.50). However, the rate of clinical events within 2 years of ART initiation appeared higher only with nevirapine (adjusted hazard ratio for composite outcome measure 1.27, 95% CI = 1.04-1.56) and abacavir (1.22, 95% CI = 1.00-1.48). CONCLUSION: Among antiretroviral-naïve patients initiating therapy, between-ART regimen, differences in short-term virologic failure do not necessarily translate to differences in clinical outcomes. Our results should be interpreted with caution because of the possibility of residual confounding by indication.

Treating tobacco use and dependence in clinical practice.

Physicians are in a unique position to advise smokers to quit by the ability to integrate the various aspects of nicotine dependence. This review provides an overview of the intervention strategies for smokers presented in a primary care setting. The strategies that are used for smoking cessation counselling differ according to the patient's readiness to quit. For smokers who do not intend to give up smoking, physicians should inform about tobacco use and the benefits of cessation. For smokers who are dissonant, physicians should use motivational strategies, such as discussing the barriers to successful cessation and their solutions. For smokers who are ready to quit, the physician should show strong support, help set a date to quit, prescribe pharmaceutical therapies for nicotine dependence, such as nicotine replacement therapy (i.e., gum, transdermal patch, nasal spray, mouth inhaler, lozenges, and micro and sublingual tablets) and/or bupropion (an atypical antidepressant thought to work by blocking the neural re-uptake of dopamine and/or noradrenaline), with instructions for use, and suggest behavioural strategies to prevent relapse. The efficacy of all of these pharmacotherapies is comparable, roughly doubling the cessation rates over control conditions.